Generation Bio (GBIO) Research & Development (2022 - 2025)
Historic Research & Development for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to $21.6 million.
- Generation Bio's Research & Development rose 4335.9% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.0 million, marking a year-over-year decrease of 780.37%. This contributed to the annual value of $61.3 million for FY2024, which is 3451.51% down from last year.
- According to the latest figures from Q3 2025, Generation Bio's Research & Development is $21.6 million, which was up 4335.9% from $15.5 million recorded in Q2 2025.
- Generation Bio's Research & Development's 5-year high stood at $28.4 million during Q2 2022, with a 5-year trough of $14.3 million in Q1 2024.
- Its 4-year average for Research & Development is $19.9 million, with a median of $21.4 million in 2022.
- As far as peak fluctuations go, Generation Bio's Research & Development crashed by 4451.17% in 2024, and later skyrocketed by 4335.9% in 2025.
- Generation Bio's Research & Development (Quarter) stood at $21.6 million in 2022, then rose by 29.23% to $27.9 million in 2023, then tumbled by 44.51% to $15.5 million in 2024, then surged by 39.6% to $21.6 million in 2025.
- Its Research & Development was $21.6 million in Q3 2025, compared to $15.5 million in Q2 2025 and $15.4 million in Q1 2025.